327 related articles for article (PubMed ID: 9463180)
41. Compromise in the treatment of hirsutism with flutamide.
Tremblay RR
In Vivo; 1993; 7(6A):549-51. PubMed ID: 8193275
[TBL] [Abstract][Full Text] [Related]
42. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
43. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
Ciotta L; Cianci A; Marletta E; Pisana L; Aglianò A; Palumbo G
Fertil Steril; 1994 Dec; 62(6):1129-35. PubMed ID: 7957975
[TBL] [Abstract][Full Text] [Related]
44. Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study.
Tartagni MV; Alrasheed H; Damiani GR; Montagnani M; De Salvia MA; De Pergola G; Tartagni M; Loverro G
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):161-5. PubMed ID: 24559619
[TBL] [Abstract][Full Text] [Related]
45. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Tartagni M; Schonauer LM; De Salvia MA; Cicinelli E; De Pergola G; D'Addario V
Fertil Steril; 2000 Apr; 73(4):718-23. PubMed ID: 10731531
[TBL] [Abstract][Full Text] [Related]
46. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Buzney E; Sheu J; Buzney C; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
[TBL] [Abstract][Full Text] [Related]
47. Finasteride in the treatment of hirsutism: new therapeutic perspectives.
Tolino A; Petrone A; Sarnacchiaro F; Cirillo D; Ronsini S; Lombardi G; Nappi C
Fertil Steril; 1996 Jul; 66(1):61-5. PubMed ID: 8752612
[TBL] [Abstract][Full Text] [Related]
48. Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
Boztosun A; Açmaz G; Ozturk A; Müderris II
Ginekol Pol; 2013 Apr; 84(4):258-62. PubMed ID: 23700857
[TBL] [Abstract][Full Text] [Related]
49. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
Harborne L; Fleming R; Lyall H; Sattar N; Norman J
J Clin Endocrinol Metab; 2003 Sep; 88(9):4116-23. PubMed ID: 12970273
[TBL] [Abstract][Full Text] [Related]
50. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Luboshitzky R; Herer P; Shen-Orr Z
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
[TBL] [Abstract][Full Text] [Related]
51. Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis.
Bashir R; Asrar MM; Shah IA; Wani IA; Ganie MA
Curr Pharm Des; 2023; 29(19):1486-1496. PubMed ID: 36999713
[TBL] [Abstract][Full Text] [Related]
52. Long-term safety and tolerability of flutamide for the treatment of hirsutism.
Castelo-Branco C; Moyano D; Gómez O; Balasch J
Fertil Steril; 2009 Apr; 91(4):1183-8. PubMed ID: 18339379
[TBL] [Abstract][Full Text] [Related]
53. I've been trying to get rid of excess facial hair ever since I can remember. Is there any effective medication for this problem?
Mayo Clin Health Lett; 1999 Feb; 17(2):8. PubMed ID: 10028912
[No Abstract] [Full Text] [Related]
54. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
Ibáñez L; Jaramillo A; Ferrer A; de Zegher F
Hum Reprod; 2005 Jul; 20(7):1833-6. PubMed ID: 15802316
[TBL] [Abstract][Full Text] [Related]
55. Spironolactone for hirsutism in polycystic ovary syndrome.
Christy NA; Franks AS; Cross LB
Ann Pharmacother; 2005 Sep; 39(9):1517-21. PubMed ID: 16076921
[TBL] [Abstract][Full Text] [Related]
56. Treatment of hirsutism with combined pill containing drospirenone.
Gregoriou O; Papadias K; Konidaris S; Bakalianou K; Salakos N; Vrachnis N; Creatsas G
Gynecol Endocrinol; 2008 Apr; 24(4):220-3. PubMed ID: 18382909
[TBL] [Abstract][Full Text] [Related]
57. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.
Unluhizarci K; Kaltsas G; Kelestimur F
Eur J Clin Invest; 2012 Jan; 42(1):86-94. PubMed ID: 21623779
[TBL] [Abstract][Full Text] [Related]
58. Investigations in the assessment and management of patients with hirsutism.
Barth JH
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):187-92. PubMed ID: 9263703
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
Taner C; Inal M; Başogul O; Onoglu A; Karanfil C; Tinar S; Ispahi C
Gynecol Obstet Invest; 2002; 54(2):105-8. PubMed ID: 12566753
[TBL] [Abstract][Full Text] [Related]
60. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism.
Dodin S; Faure N; Cédrin I; Méchain C; Turcot-Lemay L; Guy J; Lemay A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):575-82. PubMed ID: 8548942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
